These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30430372)

  • 1. Efficacy of vitamin D replacement therapy in restless legs syndrome: a randomized control trial.
    Wali SO; Abaalkhail B; Alhejaili F; Pandi-Perumal SR
    Sleep Breath; 2019 Jun; 23(2):595-601. PubMed ID: 30430372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
    Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
    Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension.
    Trenkwalder C; Beneš H; Grote L; García-Borreguero D; Högl B; Hopp M; Bosse B; Oksche A; Reimer K; Winkelmann J; Allen RP; Kohnen R;
    Lancet Neurol; 2013 Dec; 12(12):1141-50. PubMed ID: 24140442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial.
    Trenkwalder C; Benes H; Poewe W; Oertel WH; Garcia-Borreguero D; de Weerd AW; Ferini-Strambi L; Montagna P; Odin P; Stiasny-Kolster K; Högl B; Chaudhuri KR; Partinen M; Schollmayer E; Kohnen R;
    Lancet Neurol; 2008 Jul; 7(7):595-604. PubMed ID: 18515185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
    Giorgi L; Asgharian A; Hunter B
    Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial.
    Sagheb MM; Dormanesh B; Fallahzadeh MK; Akbari H; Sohrabi Nazari S; Heydari ST; Behzadi S
    Sleep Med; 2012 May; 13(5):542-5. PubMed ID: 22317944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of vitamin D on restless legs syndrome: prospective self-controlled case study.
    Tutuncu M; Tutuncu M
    Sleep Breath; 2020 Sep; 24(3):1101-1106. PubMed ID: 32078093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum 25-hydroxyvitamin D levels in restless legs syndrome patients.
    Balaban H; Yıldız ÖK; Çil G; Şentürk İA; Erselcan T; Bolayır E; Topaktaş S
    Sleep Med; 2012 Aug; 13(7):953-7. PubMed ID: 22704399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.
    Garcia-Borreguero D; Larrosa O; Williams AM; Albares J; Pascual M; Palacios JC; Fernandez C
    Neurology; 2010 Jun; 74(23):1897-904. PubMed ID: 20427750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rotigotine on daytime symptoms in patients with primary restless legs syndrome: a randomized, placebo-controlled study.
    Garcia-Borreguero D; Allen R; Hudson J; Dohin E; Grieger F; Moran K; Schollmayer E; Smit R; Winkelman J
    Curr Med Res Opin; 2016; 32(1):77-85. PubMed ID: 26569149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study.
    Oertel W; Trenkwalder C; Beneš H; Ferini-Strambi L; Högl B; Poewe W; Stiasny-Kolster K; Fichtner A; Schollmayer E; Kohnen R; García-Borreguero D;
    Lancet Neurol; 2011 Aug; 10(8):710-20. PubMed ID: 21705273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
    Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
    Neurology; 2006 Sep; 67(6):1040-6. PubMed ID: 16931508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire.
    Allen R; Oertel W; Walters A; Benes H; Schollmayer E; Grieger F; Moran K; Kohnen R
    Sleep Med; 2013 Dec; 14(12):1375-80. PubMed ID: 24246378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial.
    Dauvilliers Y; Benes H; Partinen M; Rauta V; Rifkin D; Dohin E; Goldammer N; Schollmayer E; Schröder H; Winkelman JW
    Am J Kidney Dis; 2016 Sep; 68(3):434-43. PubMed ID: 26851201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized, Placebo-Controlled Crossover Study with Dipyridamole for Restless Legs Syndrome.
    Garcia-Borreguero D; Garcia-Malo C; Granizo JJ; Ferré S
    Mov Disord; 2021 Oct; 36(10):2387-2392. PubMed ID: 34137476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study.
    Trenkwalder C; Hundemer HP; Lledo A; Swieca J; Polo O; Wetter TC; Ferini-Strambi L; de Groen H; Quail D; Brandenburg U;
    Neurology; 2004 Apr; 62(8):1391-7. PubMed ID: 15111679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.
    Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
    Neurology; 2009 Feb; 72(5):439-46. PubMed ID: 19188575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease).
    Ondo WG; Grieger F; Moran K; Kohnen R; Roth T
    J Clin Sleep Med; 2016 Jan; 12(1):63-70. PubMed ID: 26446245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome.
    Lee DO; Buchfuhrer MJ; Garcia-Borreguero D; Avidan AY; Ahmed M; Hays R; Ondo WG; Jaros MJ; Kim R; Shang G
    Sleep Med; 2016 Mar; 19():50-6. PubMed ID: 27198947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
    Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.